An Overview of Disease Burden Associated With COPD
1.0 Credit / Immunology, Pulmonology/Respiratory
View More
Foundations in Continuous Glucose Monitoring
1.0 Credit / Endocrinology, Diabetes & Metabolism
View More
Addressing the Challenges of Treating Moderate to Severe Atopic Dermatitis With Targeted Biologic Therapies in...
1.5 Credits / Allergy, Dermatology, Immunology
View More
Dual Inhibition in the Management of Moderate to Severe Asthma: Selecting the Appropriate Biologic Therapy Bas...
1.5 Credits / Allergy, Pulmonology, Immunology
View More
Biologic Therapy for the Management of Eosinophilic Esophagitis in Children: The Evolving Treatment Paradigm
1.5 Credits / Gastroenterology, Immunology
View More
Advancing Patient Outcomes in Hidradenitis Suppurativa: Updates and Strategies for Managed Care
1.5 Credits / Dermatology
View More
Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care
1.5 Credits / Dermatology, Immunology
View More
Alleviating Patient Burden in Acne: Utilizing Ceramides to Address Skin Barrier Dysfunction
0.75 Credit / Dermatology, OTC
View More
Pharmaconutrition in Practice: How Pharmacists Can Lead the Way in Patient Nutrition and Wellness
July 10th 2025Lara Zakaria, PharmD, introduced the topic of pharmaconutrition, urging pharmacists to integrate food, lifestyle, and gut health into patient care through evidence-based, practical interventions.
ATOPP 2025: Pharmacy Innovation at the Intersection of EOM and Patient Access
July 10th 2025Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC, FAPO, discusses how oncology pharmacists can lead value-based care efforts under the Enhanced Oncology Model (EOM) by improving care coordination, managing costs, aligning with performance metrics, and leveraging clinical data systems to enhance patient outcomes.
ATOPP 2025: Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC, FAPO, Highlights Must-See Sessions
July 9th 2025Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC, FAPO, discusses the value of the 2025 ATOPP Summit in advancing oncology pharmacy through collaboration, innovation, and actionable strategies aligned with evolving value-based care models.
Highlights From NLA 2025: Early LDL-C Reduction and Emerging Therapies
July 9th 2025The 2025 National Lipid Association (NLA) Scientific Sessions highlighted a strategic shift toward early, aggressive cardiometabolic intervention, underscoring the vital role of pharmacists in implementing emerging therapies and optimizing cardiovascular risk reduction.
McKesson ideaShare 2025 Set to Empower Pharmacy Professionals in Nashville
July 9th 2025Packed with CE sessions, interactive learning, expert insights, and a vibrant expo floor, McKesson ideaShare 2025 aims to equip independent pharmacists with the tools and strategies to elevate patient care and drive pharmacy innovation.